Literature DB >> 32583933

Selective anticancer activity of superparamagnetic iron oxide nanoparticles (SPIONs) against oral tongue cancer using in vitro methods: The key role of oxidative stress on cancerous mitochondria.

Jahanfar Jahanbani1, Maryam Ghotbi1, Fatemeh Shahsavari1, Enayatollah Seydi2,3, Shabnam Rahimi4, Jalal Pourahmad4.   

Abstract

Today, it has been proven that the nanoparticles such as superparamagnetic iron oxide nanoparticles (SPIONs) have widespread use in biomedical applications, for instance, in magnetic resonance imaging and targeted delivery of drugs. Despite many studies on SPIONs in diagnosing some diseases like cancer, it has not been investigated on the oral tongue squamous cell carcinoma (OTSCC) detection by the NPs. Hence, the present study has been designed to assess the in vitro cytotoxicity of SPIONs on the isolated mitochondria of OTSCC by mitochondrial tests. Isolated mitochondria were removed from the separated cancer and control tissues from the squamous cells of tango in male Wistar rats (6 or 8 weeks) and exposed to the different concentrations of SPIONs (30, 60, and 120 nM). A rise in the production of reactive oxygen species is one of the significant mechanisms of this study, followed by a collapse of mitochondrial membrane potential, the escape of mitochondrial cytochrome c, and mitochondrial swelling in the exposed isolated mitochondria of OTSCC with SPIONs. Furthermore, our results indicated that the exposure to the SPIONs reduced the activity of succinate dehydrogenase in complex II of the mitochondria obtained from cancerous oral tongue squamous. So the SPIONs can induce selective cytotoxicity on the OTSCC mitochondria without significant effects on the control mitochondria. Based on the results and further studies about in vivo experiments in this regard, it is concluded the SPIONs may be a hopeful therapeutic candidate for the treatment of OTSCC.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  cytotoxicity; mitochondria; oral tongue squamous cell carcinoma; oxidative stress; superparamagnetic iron oxide nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32583933     DOI: 10.1002/jbt.22557

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  6 in total

Review 1.  Ferrite Nanoparticles-Based Reactive Oxygen Species-Mediated Cancer Therapy.

Authors:  Shancheng Yu; Huan Zhang; Shiya Zhang; Mingli Zhong; Haiming Fan
Journal:  Front Chem       Date:  2021-04-27       Impact factor: 5.221

2.  Quality of Life in Patients With Tongue Cancer After Surgical Treatment: A 12-Month Prospective Study.

Authors:  Dimitra Palitzika; Ioannis Tilaveridis; Maria Lavdaniti; Konstantinos Vahtsevanos; Angeliki Kosintzi; Konstantinos Antoniades
Journal:  Cureus       Date:  2022-02-23

Review 3.  Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy.

Authors:  Jiangsheng Xu; James G Shamul; Elyahb Allie Kwizera; Xiaoming He
Journal:  Nanomaterials (Basel)       Date:  2022-02-23       Impact factor: 5.719

4.  1,2-Dimyristoyl-sn-glycero-3-phosphocholine promotes the adhesion of nanoparticles to bio-membranes and transport in rat brain.

Authors:  Dong Han; Baolin Zhang; Jianghui Dong; Boning Yang; Yuntao Peng; Junfeng Wang; Liping Wang
Journal:  RSC Adv       Date:  2021-11-03       Impact factor: 4.036

5.  Atranorin driven by nano materials SPION lead to ferroptosis of gastric cancer stem cells by weakening the mRNA 5-hydroxymethylcytidine modification of the Xc-/GPX4 axis and its expression.

Authors:  Zhentian Ni; Xiaoli Nie; Hairong Zhang; Lingquan Wang; Zixiang Geng; Xiling Du; Haiyang Qian; Wentao Liu; Te Liu
Journal:  Int J Med Sci       Date:  2022-09-25       Impact factor: 3.642

6.  Designing of Co0.5Ni0.5GaxFe2-xO4 (0.0 ≤ x ≤ 1.0) Microspheres via Hydrothermal Approach and Their Selective Inhibition on the Growth of Cancerous and Fungal Cells.

Authors:  Suriya Rehman; Munirah A Almessiere; Suhailah S Al-Jameel; Uzma Ali; Yassine Slimani; Nedaa Tashkandi; Najat S Al-Saleh; Ayyar Manikandan; Firdos Alam Khan; Ebtesam A Al-Suhaimi; Abdulhadi Baykal
Journal:  Pharmaceutics       Date:  2021-06-26       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.